The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Study enrollment to assess Feasibility
Timeframe: 16 weeks
Mean number treatment sessions attended to assess Feasibility
Timeframe: 16 weeks
Retention to assess Feasibility
Timeframe: 16 weeks
Treatment credibility to assess Acceptability
Timeframe: Week 4, Week 8, Week 12, Week 16
Treatment satisfaction to assess Acceptability
Timeframe: Week 16
Percent weight change
Timeframe: Baseline, Week 16, 6-month follow-up
Smoking cessation, as measured by exhaled carbon monoxide
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, 6-month follow-up
Smoking cessation, as measured by timeline followback interview
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, 6-month follow-up